CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study - Trial NCT06106776
Access comprehensive clinical trial information for NCT06106776 through Pure Global AI's free database. This phase not specified trial is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS and is currently Not yet recruiting. The study focuses on Lymphoma. Target enrollment is 48 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Timeline & Enrollment
N/A
Nov 02, 2023
Jan 31, 2026
Primary Outcome
Incidence of Cancer Therapy Related Cardiac Dysfunction
Summary
In this observational, prospective study, patients affected by B-cell Lymphoma and candidate
 to chimeric antigen receptor-T (CAR-T) cell infusion will be evaluated at three timepoints to
 establish the rate of cardiac dysfunction, defined according to 2022 European Society of
 Cardiology Cardio-Oncology guidelines. Echocardiography, physical examination and
 cardiac/inflammatory biomarkers will be performed prior to CAR-T cell infusion and followed
 at 7 days and 1 month.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06106776
Non-Device Trial